Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials

2021|PLoS ONE|Wu YB, Dai YK, Zhang L, Pan HG, Chen WJ, Li RL, Hu L
Strong

Study Type

systematic review

Human / Animal / In Vitro

human

Sample Size

3323

Evidence Snapshot

Traditional Use
Strong
Human Evidence
Strong
Research Consistency
Insufficient
Safety Evidence
Insufficient

Abstract

This network meta-analysis of 28 RCTs involving 3,323 patients evaluated Chinese herbal medicine (CHM) for IBS. Jianpi-Chushi therapy showed significant improvement in adequate relief and IBS symptom severity scale (IBS-SSS). Shugan-Jianpi therapy showed the best efficacy in relieving abdominal pain and distension. Wenshen-Jianpi therapy had a better effect on avoiding adverse effects and improving stool character. GRADE evidence quality: Low.

Original Source

References

References are being reviewed
Published July 2, 2026Reviewed content

Medical Disclaimer: The information on TCMIO is provided for educational purposes only. It is not intended as medical advice, diagnosis, or treatment.

Always consult a qualified healthcare professional before using any herbal products, starting any new treatment, or making changes to your existing healthcare regimen. Do not stop or modify any prescribed treatment without consulting your healthcare provider.

If you are experiencing severe or urgent symptoms, seek immediate medical attention by calling emergency services or visiting the nearest emergency department.